AKT1 and central nervous system cancer: Overexpression of glucose transporters and upregulation of the PI3k-Akt-mTOR signaling support the energy demand associated with this metabolic reprogramming and blockade of this pathway using an Akt inhibitor has shown to decrease glioma growth (16, 253–255).